Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.

@article{Kim2008SystemicBO,
  title={Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.},
  author={Samuel F. Kim and George Buchlis and Zvi Gregory Fridlender and Jing Sun and Veena Kapoor and Guanjun Cheng and Andrew D. Haas and Hung Kam Cheung and Xiamei Zhang and Michael J. Corbley and Larry Robert Kaiser and Leona E Ling and Steven M. Albelda},
  journal={Cancer research},
  year={2008},
  volume={68 24},
  pages={10247-56}
}
Locally produced transforming growth factor-beta (TGF-beta) promotes tumor-induced immunosuppression and contributes to resistance to immunotherapy. This article explores the potential for increased efficacy when combining immunotherapies with TGF-beta suppression using the TGF-beta type I receptor kinase inhibitor SM16. Adenovirus expressing IFN-beta (Ad.IFN-beta) was injected intratumorally once in established s.c. AB12 (mesothelioma) and LKR (lung cancer) tumors or intratracheally in a Kras… CONTINUE READING
41 Citations
51 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Soluble type II transforming growth factor-h receptor inhibits both small and large established murine malignant mesothelioma tumor growth by augmenting host anti-tumor immunity

  • E Suzuki, V Kapoor, HK Cheung
  • Clin Cancer Res
  • 2004
Highly Influential
5 Excerpts

A phase I clinical trial of single-dose intrapleural interferon-h gene transfer for malignant mesothelioma and metastatic pleural effusions: high rate of anti-tumor immune responses

  • DH Sterman, AR Recio, RG Carroll
  • Clin Cancer Res 2007;13:4456–66
  • 2008

An orally active inhibitor of the TGF-h type I receptor, ALK5, inhibits vascular fibrosis and adventitial myofibroblast induction in the rat carotid balloon injury model

  • K Fu, MJ Corbley, L Sun
  • Arterioscler Thromb Vasc Biol 2008;28:665–71
  • 2008
2 Excerpts

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino TGF-b Blockade Augments Immunogene Therapy www.aacrjournals.org

  • PC Rodriguez, AC Ochoa
  • Cancer Res
  • 2008

TGF-h receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid tumors

  • A Wallace, V Kapoor, J Sun
  • Clin Cancer Res
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…